Oncology & Cancer

Niraparib extends time without symptoms in ovarian cancer

(HealthDay)—Women with recurrent ovarian cancer who receive the poly ADP ribose polymerase (PARP) inhibitor niraparib as maintenance therapy after treatment have both more time without side effects and significantly longer ...

Overweight & Obesity

Say no to yo-yo dieting

(HealthDay)—New to weight loss or tired of yo-yo dieting? Learning "stability skills" first may lead to greater long-term weight loss success.

Psychology & Psychiatry

Relationship science: How can couples keep moving forward

For some couples in romantic relationships, just staying together is good enough. But others want to see their relationship move forward—to get better and better—and are willing to put in the effort to get there.

page 1 from 5